Immunology, Serology, Internal medicine, Virology and Viral disease are her primary areas of study. The study incorporates disciplines such as Young adult and Cardiopulmonary disease in addition to Immunology. Her Internal medicine study incorporates themes from Influenza A virus and Antibiotics.
In her research, Ann R. Falsey performs multidisciplinary study on Virology and Coronavirus. Her Viral disease research incorporates elements of Respiratory disease, Neutralizing antibody and Risk factor. Her Vaccination research focuses on Immunogenicity and how it relates to Adverse effect.
Her primary areas of study are Immunology, Virology, Virus, Internal medicine and Respiratory system. Her studies in Immunology integrate themes in fields like Respiratory disease and Pneumonia. The various areas that she examines in her Virology study include Human metapneumovirus and Humoral immunity.
Her study looks at the relationship between Virus and fields such as Serology, as well as how they intersect with chemical problems. Her Respiratory system research incorporates themes from COPD, Physiology and Polymerase chain reaction. Her research investigates the connection between Vaccination and topics such as Immunogenicity that intersect with problems in Adverse effect.
The scientist’s investigation covers issues in Immunology, Virus, Respiratory system, Virology and Internal medicine. Her studies deal with areas such as Gene expression and Airway as well as Immunology. Her work carried out in the field of Virus brings together such families of science as Respiratory tract infections, Incidence, Cohort and Clinical trial.
Her Virology research integrates issues from Human metapneumovirus, Polymerase chain reaction, Respiratory Syncytial Virus Vaccines and Immunogenicity. Her study in the field of Reactogenicity is also linked to topics like Pandemic. Her work in the fields of Internal medicine, such as Functional status, Odds ratio, Cumulative incidence and Rhinovirus, intersects with other areas such as In patient.
Her main research concerns Immunogenicity, Antibody, Immunology, Internal medicine and Virology. Her Reactogenicity study in the realm of Immunogenicity connects with subjects such as Severe acute respiratory syndrome coronavirus 2. Her research in the fields of Titer and Virus overlaps with other disciplines such as Pandemic.
Her research ties Antibiotics and Internal medicine together. Her research integrates issues of Global health, Respiratory Syncytial Virus Vaccines, Burden of disease and Clinical trial in her study of Virology. Her Disease research is multidisciplinary, incorporating perspectives in Efficacy Study and Adverse effect.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Respiratory syncytial virus infection in elderly and high-risk adults.
Ann R. Falsey;Patricia A. Hennessey;Maria A. Formica;Christopher Cox.
The New England Journal of Medicine (2005)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin.
The New England Journal of Medicine (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon.
Respiratory Syncytial Virus Infection in Adults
Ann R. Falsey;Edward E. Walsh.
Clinical Microbiology Reviews (2000)
Human Metapneumovirus Infections in Young and Elderly Adults
Ann R Falsey;Dean Erdman;Larry J Anderson;Edward E Walsh.
The Journal of Infectious Diseases (2003)
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Philipp Schuetz;Yannick Wirz;Ramon Sager;Mirjam Christ-Crain.
Cochrane Database of Systematic Reviews (2017)
Respiratory Syncytial Virus and Influenza A Infections in the Hospitalized Elderly
Ann R. Falsey;Coleen K. Cunningham;William H. Barker;Ruth W. Kouides.
The Journal of Infectious Diseases (1995)
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older
Ann R. Falsey;John J. Treanor;Nadia Tornieporth;Jose Capellan.
The Journal of Infectious Diseases (2009)
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
Philipp Schuetz;Yannick Wirz;Ramon Sager;Mirjam Christ-Crain;Mirjam Christ-Crain.
Lancet Infectious Diseases (2018)
Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.
Jessica L. Halliley;Jessica L. Halliley;Christopher M. Tipton;Jane Liesveld;Alexander F. Rosenberg.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: